Liver-produced IFN-I is known to promote the occurrence and development of HFD-induced NAFLD in mice, which is specifically related to the activation of CD8+T cells and leads to insulin resistance and liver gluconeogenesis (28). Here, CD8A is linked to metabolic dysfunction-associated steatotic liver disease.